ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Evolutionary Genomics Inc Common Stock (CE)

Evolutionary Genomics Inc Common Stock (CE) (FNAM)

0.0008
0.00
(0.00%)
Closed December 03 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.0008
Bid
0.00
Ask
0.00
Volume
-
0.00 Day's Range 0.00
0.0008 52 Week Range 0.45
Market Cap
Previous Close
0.0008
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
6,655,232
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-0.34
Revenue
-
Net Profit
-2.25M

About Evolutionary Genomics Inc Common Stock (CE)

The company engages in agricultural research. The company engages in agricultural research.

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Las Vegas, Nevada, USA
Founded
-
Evolutionary Genomics Inc Common Stock (CE) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker FNAM. The last closing price for Evolutionary Genomics In... (CE) was $0. Over the last year, Evolutionary Genomics In... (CE) shares have traded in a share price range of $ 0.0008 to $ 0.45.

Evolutionary Genomics In... (CE) currently has 6,655,232 shares outstanding. The market capitalization of Evolutionary Genomics In... (CE) is $5,324.19 . Evolutionary Genomics In... (CE) has a price to earnings ratio (PE ratio) of 0.00.

FNAM Latest News

CREDIT MARKETS: 'Risk On' Aids Corporates, Lifts Safe-Haven Yields

The global search for yield drove money into bank bonds and lifted safe-haven yields Friday. The benchmark 10-year Treasury yield jumped nearly five basis points Friday to finish the week at...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
12000.00080.00080.000800CS
26-0.4492-99.82222222220.450.450.000831660.0008CS
52-0.4492-99.82222222220.450.450.000826390.0008CS
156-0.8092-99.90123456790.810.810.000816350.5426685CS
260-1.4992-99.94666666671.55.710.000816090.90360943CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KBNTKubient Inc (CE)
$ 0.0003
(29,900.00%)
400
YAYOYayYo Inc (CE)
$ 0.0002
(19,900.00%)
15.71k
NHIQNantHealth Inc (CE)
$ 0.25
(12,400.00%)
1.12k
ARDSAridis Pharmaceuticals Inc (CE)
$ 0.0001
(9,900.00%)
33.37k
NSTBNorthern Star Investment Corporation II (CE)
$ 0.01
(9,900.00%)
300
CLVRClever Leaves Holdings Inc (CE)
$ 0.0002
(-99.98%)
676
CITLFCritical Infrastructure Technologies Ltd (PK)
$ 0.0001
(-99.96%)
500
RQHTFReliq Health Technologies Inc (CE)
$ 0.000001
(-99.91%)
100
EORBFOrbite Technologies Inc (CE)
$ 0.000001
(-99.69%)
95.8k
ANTHAnthera Pharmaceuticals Inc (CE)
$ 0.000001
(-99.50%)
428
RDARRaadr Inc (PK)
$ 0.0011
(29.41%)
407.34M
CMGRClubhouse Media Group Inc (PK)
$ 0.0001
(0.00%)
304.71M
DPUIDiscount Print USA Inc (PK)
$ 0.0003
(50.00%)
187.09M
HMBLHUMBL Inc (PK)
$ 0.0003
(50.00%)
105.08M
DRNGDrone Guarder Inc (PK)
$ 0.00025
(25.00%)
88.96M

FNAM Discussion

View Posts
adijas adijas 4 years ago
From last Q

Subsequent Events: The Company has evaluated all subsequent events through the date of this filing. On August 19, 2020, the Company entered into a Development and Commercialization Agreement with Dole Food Company for the development of plant varieties within the Musa genus of the Musaceae family (including the Cavendish variety of banana) that exhibit resistance to Fusarium Wilt Tropical Race 4 (popularly known as Panama Disease). Subject to compliance with various provisions of the agreement, the agreement includes working capital funding from Dole to the Company over the next four years. In addition to working capital funding, Dole will reimburse the Company for the development of banana plants and incur additional costs for the commercialization of plants upon successful completion of the development portion of this project. Per the Agreement, 50% of future royalties may be offset with the research funding provided by Dole. In the event that Dole terminates the agreement for material breach by the Company or the Company’s bankruptcy, the Company must repay all funding provided by Dole balances to Dole within six months of termination. The parties have agreed to negotiate the terms of the long-term license agreement upon successful completion of the development portion of this project.

Dole is huge https://en.wikipedia.org/wiki/Dole_Food_Company

👍️0
RickNagra RickNagra 8 years ago
Looks like tomorrow could be epic.
👍️0
tedpeele tedpeele 9 years ago
124k shares or 6m?
👍️0
Renee Renee 9 years ago
Fona Inc. changed to Evolutionary Genomics Inc. and a one for 60.88 reverse split:

http://otce.finra.org/DLSymbolNameChanges
👍️0
kranthikumar kranthikumar 11 years ago
FNAM is getting attension and momentum
👍️0